[Sports Seoul] Kyung Hee Medical Science Research Institute Signs MOU with StemExOne for Clinical Research and Development of Exosome Therapeutics

Ssang-Goo Cho, CEO of StemExOne (left), and Yoon Kyung-sik, Director of the Kyung Hee Medical Science Research Institute, pose for a commemorative photo following the signing of the MOU.
Photo courtesy of Kyung Hee University Medical Center

[Sports Seoul, Reporter Hwang Cheol-hoon] The Kyung Hee Medical Science Research Institute announced on the 23rd that it signed a memorandum of understanding with StemExOne on the 17th to collaborate on clinical research and the development of exosome-based therapeutics.

Exosomes are a type of extracellular vesicle (EV) released by cells and serve as biological messengers that facilitate intercellular communication and signal transmission.

Around 10 representatives attended the signing ceremony, including Yoon Kyung-sik, Director of the Kyung Hee Medical Science Research Institute; Prof. Ki-Heon Jeong of the Department of Dermatology at Kyung Hee University Hospital; Ssang-Goo Cho, CEO of StemExOne; and Geun-Ho Kang, Team Leader at StemExOne.

Under the agreement, the two organizations plan to conduct joint research on exosome-based clinical applications and therapeutics, while also participating in government-funded industry-academia collaboration projects.

Ssang-Goo Cho, CEO of StemExOne, said, “Through close collaboration with the outstanding researchers at the Kyung Hee Medical Science Research Institute, we will actively leverage our technologies for large-scale exosome production and specialized drug delivery systems (DDS). By doing so, we aim to advance government-funded R&D projects and lead the development of effective therapeutics for refractory diseases.”

Yoon Kyung-sik, Director of the Kyung Hee Medical Science Research Institute, said, “Centered on the Exosome Research Group and the Institute of Regenerative Medicine at Kyung Hee University Medical Center, we will actively support the broad application of these technologies to clinical research in a range of diseases, including skin disorders, ocular and oral dryness, and interstitial cystitis.”